Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis

Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis

Background: Dipeptidyl peptidase-4 inhibitors (DPP4I) may be associated with higher risks of acute pancreatitis and pancreatic cancer. This study compared the risks of acute pancreatitis and pancreatic cancer between sodium glucose cotransporter 2 inhibitors (SGLT2I) and DPP4I users. Methods: This w...

Full description

Bibliographic Details
Main Authors: Oscar Hou In Chou, Jiandong Zhou, Jonathan V Mui, MBBChir, Danish Iltaf Satti, Cheuk To Chung, Teddy Tai Loy Lee, Sharen Lee, Edward Christopher Dee, Kenrick Ng, MBBChir, Bernard Man Yung Cheung, Fengshi Jing, Gary Tse
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Diabetes Epidemiology and Management
Online Access:http://www.sciencedirect.com/science/article/pii/S2666970622000658

Internet

http://www.sciencedirect.com/science/article/pii/S2666970622000658

Similar Items